STOCK TITAN

Gritstone bio to Present at 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Gritstone bio, a clinical-stage biotechnology company, will present at the 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023. CEO Andrew Allen will speak from 9:45 to 10:25 AM Pacific Time, discussing the company’s efforts to develop potent vaccines targeting critical diseases. A live webcast will be available, and an archived version can be accessed for 30 days after the event. Gritstone is focused on advancing innovative vaccine candidates to improve patient outcomes in viral diseases and solid tumors.

Positive
  • None.
Negative
  • None.

EMERYVILLE, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that Andrew Allen, M.D., Ph.D., Co-founder, President and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference occurring January 9-12, 2023 in San Francisco. The presentation will take place on Thursday, January 12, 2023 from 9:45 - 10:25 AM Pacific Time in Elizabethan A conference room.

A webcast of the presentation will be available at https://ir.gritstonebio.com/investors/events. An archived replay will be accessible for 30 days following the event.

About Gritstone bio
Gritstone is working to create the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets and have programs in viral diseases and solid tumors. Independently and with our partners, we are advancing a portfolio of product candidates with the aim of improving patient outcomes and eliminating disease. www.gritstonebio.com

Gritstone Contacts
Investors:
George E. MacDougall
Director, Investor Relations & Corporate Communications
Gritstone bio, Inc.
ir@gritstone.com

Media:
Dan Budwick
1AB
(973) 271-6085
dan@1abmedia.com


FAQ

When is Gritstone bio's presentation at the J.P. Morgan Healthcare Conference?

Gritstone bio will present on January 12, 2023, from 9:45 to 10:25 AM Pacific Time.

Who is presenting for Gritstone bio at the conference?

CEO Andrew Allen will present for Gritstone bio.

How can I watch Gritstone bio's presentation at the conference?

A live webcast of the presentation will be available online with an archived replay accessible for 30 days post-event.

What is the focus of Gritstone bio's research?

Gritstone bio is developing vaccines targeting viral diseases and solid tumors to improve patient outcomes.

What is the stock symbol for Gritstone bio?

The stock symbol for Gritstone bio is GRTS.

Gritstone bio, Inc.

NASDAQ:GRTS

GRTS Rankings

GRTS Latest News

GRTS Stock Data

3.80M
118.11M
1.91%
29.03%
6.37%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
EMERYVILLE